• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas系统及其影响精度和效率的因素

CRISPR/Cas System and Factors Affecting Its Precision and Efficiency.

作者信息

Javaid Nasir, Choi Sangdun

机构信息

Department of Molecular Science and Technology, Ajou University, Suwon, South Korea.

S&K Therapeutics, Ajou University Campus Plaza, Suwon, South Korea.

出版信息

Front Cell Dev Biol. 2021 Nov 24;9:761709. doi: 10.3389/fcell.2021.761709. eCollection 2021.

DOI:10.3389/fcell.2021.761709
PMID:34901007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652214/
Abstract

The diverse applications of genetically modified cells and organisms require more precise and efficient genome-editing tool such as clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas). The CRISPR/Cas system was originally discovered in bacteria as a part of adaptive-immune system with multiple types. Its engineered versions involve multiple host DNA-repair pathways in order to perform genome editing in host cells. However, it is still challenging to get maximum genome-editing efficiency with fewer or no off-targets. Here, we focused on factors affecting the genome-editing efficiency and precision of CRISPR/Cas system along with its defense-mechanism, orthologues, and applications.

摘要

基因编辑细胞和生物体的多种应用需要更精确、高效的基因组编辑工具,如成簇规律间隔短回文重复序列/CRISPR相关蛋白(CRISPR/Cas)。CRISPR/Cas系统最初是在细菌中作为具有多种类型的适应性免疫系统的一部分被发现的。其工程化版本涉及多种宿主DNA修复途径,以便在宿主细胞中进行基因组编辑。然而,要在脱靶较少或无脱靶的情况下获得最大的基因组编辑效率仍然具有挑战性。在这里,我们重点关注了影响CRISPR/Cas系统基因组编辑效率和精准度的因素,以及其防御机制、直系同源物和应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/01ad57b4c5cb/fcell-09-761709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/a21903a333ab/fcell-09-761709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/b96d2e6a5f20/fcell-09-761709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/201ccc0665af/fcell-09-761709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/c7270e02f864/fcell-09-761709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/308c08f88747/fcell-09-761709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/01ad57b4c5cb/fcell-09-761709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/a21903a333ab/fcell-09-761709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/b96d2e6a5f20/fcell-09-761709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/201ccc0665af/fcell-09-761709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/c7270e02f864/fcell-09-761709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/308c08f88747/fcell-09-761709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30b5/8652214/01ad57b4c5cb/fcell-09-761709-g006.jpg

相似文献

1
CRISPR/Cas System and Factors Affecting Its Precision and Efficiency.CRISPR/Cas系统及其影响精度和效率的因素
Front Cell Dev Biol. 2021 Nov 24;9:761709. doi: 10.3389/fcell.2021.761709. eCollection 2021.
2
Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.成簇规律间隔短回文重复序列和成簇规律间隔短回文重复序列相关蛋白 9 系统:影响精确基因编辑效率的因素和优化策略。
Hum Gene Ther. 2023 Dec;34(23-24):1190-1203. doi: 10.1089/hum.2023.115. Epub 2023 Oct 17.
3
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.CRISPR/Cas:一项获得诺贝尔奖的精确基因组编辑技术,可用于基因治疗和作物改良。
J Zhejiang Univ Sci B. 2021 Apr 15;22(4):253-284. doi: 10.1631/jzus.B2100009.
4
CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.CRISPR-Cas系统:作为微生物基因组编辑工具的历史与前景
Curr Microbiol. 2018 Dec;75(12):1675-1683. doi: 10.1007/s00284-018-1547-4. Epub 2018 Aug 4.
5
Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.成簇规律间隔短回文重复序列(CRISPR)作为治疗癌症的基因手术刀的应用:一项转化性叙述性综述
Cureus. 2023 Dec 6;15(12):e50031. doi: 10.7759/cureus.50031. eCollection 2023 Dec.
6
[Advances in CRISPR-Cas-mediated genome editing system in plants].[CRISPR-Cas介导的植物基因组编辑系统研究进展]
Sheng Wu Gong Cheng Xue Bao. 2017 Oct 25;33(10):1712-1722. doi: 10.13345/j.cjb.170170.
7
[Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].[由CRISPR/Cas核糖核蛋白复合体介导的植物基因组编辑]
Yi Chuan. 2020 Jun 20;42(6):556-564. doi: 10.16288/j.yczz.20-017.
8
The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.CRISPR的快速发展:从实验室到临床应用的多功能小RNA
J Microbiol Biotechnol. 2017 Feb 28;27(2):207-218. doi: 10.4014/jmb.1607.07005.
9
Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.CRISPR-Cas 系统基因组编辑:艺术、伦理和全球监管视角。
Plant Biotechnol J. 2020 Aug;18(8):1651-1669. doi: 10.1111/pbi.13383. Epub 2020 Apr 30.
10
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.CRISPR/Cas:精准癌症研究的进展、局限与应用
Front Med (Lausanne). 2021 Mar 3;8:649896. doi: 10.3389/fmed.2021.649896. eCollection 2021.

引用本文的文献

1
Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations.增强特异性、精准性、可及性、灵活性和安全性,以克服传统CRISPR/Cas编辑挑战并塑造未来创新。
Adv Sci (Weinh). 2025 Jul;12(28):e2416331. doi: 10.1002/advs.202416331. Epub 2025 Jun 23.
2
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors.基于适配体联合CRISPR/Cas系统的生物传感器信号转换研究进展
Mol Diagn Ther. 2025 Jun 18. doi: 10.1007/s40291-025-00785-7.
3
Unveiling the Therapeutic Potential of Targeting RRM2 in Hepatocellular Carcinoma: An Integrated In Silico and In Vitro Study.

本文引用的文献

1
Structural mechanism of DNA-mediated Nanog-Sox2 cooperative interaction.DNA介导的Nanog-Sox2协同相互作用的结构机制
RSC Adv. 2019 Mar 13;9(14):8121-8130. doi: 10.1039/c8ra10085c. eCollection 2019 Mar 6.
2
CRISPR-Cas system enables fast and simple genome editing of industrial strains.CRISPR-Cas系统可实现工业菌株基因组的快速简易编辑。
Metab Eng Commun. 2015 Mar 20;2:13-22. doi: 10.1016/j.meteno.2015.03.001. eCollection 2015 Dec.
3
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.
揭示靶向核糖核苷酸还原酶M2亚基在肝细胞癌中的治疗潜力:一项计算机模拟和体外实验相结合的研究
Funct Integr Genomics. 2025 Jun 10;25(1):123. doi: 10.1007/s10142-025-01630-0.
4
Cas11 augments Cascade functions in type I-E CRISPR system but is redundant for gene silencing and plasmid interference.Cas11增强了I-E型CRISPR系统中的Cascade功能,但在基因沉默和质粒干扰方面是多余的。
Biochem J. 2025 Jun 11;482(12):BCJ20253056. doi: 10.1042/BCJ20253056.
5
Genome Editing in Gynecological Oncology: The Emerging Role of CRISPR/Cas9 in Precision Cancer Therapy.妇科肿瘤学中的基因组编辑:CRISPR/Cas9在精准癌症治疗中的新兴作用
Ther Innov Regul Sci. 2025 May 20. doi: 10.1007/s43441-025-00807-w.
6
Comparative analysis of multiple DNA double-strand break repair pathways in CRISPR-mediated endogenous tagging.CRISPR介导的内源性标记中多种DNA双链断裂修复途径的比较分析
Commun Biol. 2025 May 13;8(1):749. doi: 10.1038/s42003-025-08187-5.
7
Viral-Based Gene Editing System for Nutritional Improvement of Fructan Content in Lettuce.用于改善生菜果聚糖含量的基于病毒的基因编辑系统。
Int J Mol Sci. 2025 Mar 13;26(6):2594. doi: 10.3390/ijms26062594.
8
Important applications of DNA nanotechnology combined with CRISPR/Cas systems in biotechnology.DNA纳米技术与CRISPR/Cas系统相结合在生物技术中的重要应用。
RSC Adv. 2025 Feb 25;15(8):6208-6230. doi: 10.1039/d4ra08325c. eCollection 2025 Feb 19.
9
Breaking Barriers to an HIV-1 Cure: Innovations in Gene Editing, Immune Modulation, and Reservoir Eradication.突破治愈HIV-1的障碍:基因编辑、免疫调节和病毒储存库清除方面的创新
Life (Basel). 2025 Feb 11;15(2):276. doi: 10.3390/life15020276.
10
Synergizing CRISPR-Cas9 with Advanced Artificial Intelligence and Machine Learning for Precision Drug Delivery: Technological Nexus and Regulatory Insights.将CRISPR-Cas9与先进的人工智能和机器学习相结合以实现精准药物递送:技术关联与监管见解。
Curr Gene Ther. 2025;25(4):467-496. doi: 10.2174/0115665232342293241120033251.
SARS-CoV-2 与 COVID-19:遗传、流行病学和进化角度的分析。
Infect Genet Evol. 2020 Oct;84:104384. doi: 10.1016/j.meegid.2020.104384. Epub 2020 May 29.
4
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.CRISPR 作为抗病毒策略的发展,以对抗 SARS-CoV-2 和流感。
Cell. 2020 May 14;181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020. Epub 2020 Apr 29.
5
CRISPR-Cas12-based detection of SARS-CoV-2.基于 CRISPR-Cas12 的 SARS-CoV-2 检测。
Nat Biotechnol. 2020 Jul;38(7):870-874. doi: 10.1038/s41587-020-0513-4. Epub 2020 Apr 16.
6
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.无约束基因组靶向的近无 PAM 工程化 CRISPR-Cas9 变体。
Science. 2020 Apr 17;368(6488):290-296. doi: 10.1126/science.aba8853. Epub 2020 Mar 26.
7
Highly Parallel Profiling of Cas9 Variant Specificity.高通量分析 Cas9 变体特异性。
Mol Cell. 2020 May 21;78(4):794-800.e8. doi: 10.1016/j.molcel.2020.02.023. Epub 2020 Mar 17.
8
CRISPR'd babies: human germline genome editing in the 'He Jiankui affair'.基因编辑婴儿:“贺建奎事件”中的人类生殖系基因组编辑
J Law Biosci. 2019 Aug 13;6(1):111-183. doi: 10.1093/jlb/lsz010. eCollection 2019 Oct.
9
Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.针对视紫红质相关显性视网膜色素变性的单碱基P23H突变进行等位基因特异性CRISPR-Cas9基因组编辑
CRISPR J. 2018 Feb;1(1):55-64. doi: 10.1089/crispr.2017.0009.
10
Optimizing genome editing strategy by primer-extension-mediated sequencing.通过引物延伸介导的测序优化基因组编辑策略。
Cell Discov. 2019 Mar 26;5:18. doi: 10.1038/s41421-019-0088-8. eCollection 2019.